Granting of Stock Options and Vesting of Restricted Share Units
Alvotech (ALVO) has announced the granting of stock options to four independent board directors and the vesting of previously awarded Restricted Share Units (RSUs). Each director received options to purchase 24,784 Alvotech shares at an exercise price of $9.28 per share.
The stock options will vest over a three-year period, with one-third vesting each year starting from the grant date of June 25, 2025. Directors must remain board members at the time of vesting to exercise their options. The exercise price was determined by the opening price of Alvotech's ordinary shares on Nasdaq US on the grant date.
Alvotech (ALVO) ha annunciato la concessione di opzioni su azioni a quattro membri indipendenti del consiglio di amministrazione e il consolidamento di Restricted Share Units (RSU) precedentemente assegnate. Ogni direttore ha ricevuto opzioni per acquistare 24.784 azioni Alvotech a un prezzo di esercizio di 9,28 $ per azione.
Le opzioni su azioni matureranno in un periodo di tre anni, con un terzo che matura ogni anno a partire dalla data di assegnazione del 25 giugno 2025. I direttori devono rimanere membri del consiglio al momento della maturazione per poter esercitare le opzioni. Il prezzo di esercizio è stato determinato dal prezzo di apertura delle azioni ordinarie Alvotech sul Nasdaq US nella data di assegnazione.
Alvotech (ALVO) ha anunciado la concesión de opciones sobre acciones a cuatro directores independientes del consejo y la consolidación de Unidades de Acciones Restringidas (RSU) previamente otorgadas. Cada director recibió opciones para comprar 24,784 acciones de Alvotech a un precio de ejercicio de $9.28 por acción.
Las opciones sobre acciones se consolidarán durante un período de tres años, con un tercio consolidándose cada año a partir de la fecha de concesión del 25 de junio de 2025. Los directores deben seguir siendo miembros del consejo en el momento de la consolidación para poder ejercer sus opciones. El precio de ejercicio se determinó según el precio de apertura de las acciones ordinarias de Alvotech en Nasdaq US en la fecha de concesión.
Alvotech (ALVO)는 네 명의 독립 이사들에게 주식 매수선택권을 부여하고 이전에 수여된 제한 주식 단위(RSU)의 권리 확정을 발표했습니다. 각 이사는 24,784주의 Alvotech 주식을 주당 9.28달러의 행사가격으로 매수할 수 있는 옵션을 받았습니다.
주식 매수선택권은 3년 동안 매년 3분의 1씩 권리가 확정되며, 2025년 6월 25일 부여일로부터 시작됩니다. 이사들은 권리 확정 시점에 이사회 멤버로 남아 있어야 옵션을 행사할 수 있습니다. 행사가격은 부여일에 Nasdaq US에서 Alvotech 보통주의 시가를 기준으로 결정되었습니다.
Alvotech (ALVO) a annoncé l'attribution d'options d'achat d'actions à quatre administrateurs indépendants ainsi que la levée des Restricted Share Units (RSU) précédemment attribuées. Chaque administrateur a reçu des options pour acheter 24 784 actions Alvotech au prix d'exercice de 9,28 $ par action.
Les options d'achat d'actions seront acquises sur une période de trois ans, avec un tiers qui sera acquis chaque année à partir de la date d'attribution, le 25 juin 2025. Les administrateurs doivent rester membres du conseil au moment de l'acquisition pour pouvoir exercer leurs options. Le prix d'exercice a été déterminé par le cours d'ouverture des actions ordinaires d'Alvotech sur le Nasdaq US à la date d'attribution.
Alvotech (ALVO) hat die Gewährung von Aktienoptionen an vier unabhängige Vorstandsmitglieder sowie die Freigabe zuvor zugeteilter Restricted Share Units (RSUs) bekannt gegeben. Jeder Direktor erhielt Optionen zum Kauf von 24.784 Alvotech-Aktien zu einem Ausübungspreis von 9,28 $ pro Aktie.
Die Aktienoptionen werden über einen Zeitraum von drei Jahren mit jeweils einem Drittel pro Jahr ab dem Gewährungsdatum am 25. Juni 2025 freigegeben. Die Direktoren müssen zum Zeitpunkt der Freigabe Vorstandsmitglieder bleiben, um ihre Optionen ausüben zu können. Der Ausübungspreis wurde anhand des Eröffnungskurses der Alvotech-Stammaktien an der Nasdaq US am Gewährungstag festgelegt.
- None.
- None.
In accordance with the Remuneration Policy of Alvotech (the “Company”), which was approved at the Company’s Annual General Meeting (“AGM”) on June 6, 2023, at the 2025 AGM held on June 25, 2025, four independent board directors each received a stock option grant allowing the purchase of up to 24,784 Alvotech shares.
The aim of the stock option grants is to align the long-term interests of the board members and the Company. The relevant key terms and conditions of the Company´s Equity Incentive Plan approved by Alvotech’s Annual and Extraordinary General Meeting on June 13, 2022 are as follows:
- The stock option agreements entitle the grantee to purchase Alvotech shares at an exercise price of USD 9.28 per share*.
- The options are subject to a vesting period over three years with yearly vesting, i.e. one third of the options vest each year starting on the AGM where the stock options were awarded.
- The options are only exercisable if the grantee is still a member of the board of Alvotech at the time of vesting.
Attached to this announcement are filings with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) made by the respective four independent board directors of their vested RSUs, in accordance with previous grants.
*The exercise price is determined by the opening price of the Company's ordinary shares on the Nasdaq US stock exchange on the date of the grant, in this case on June 25, 2025.
Alvotech Investor Relations
Benedikt Stefansson, VP
alvotech.ir@alvotech.com
Attachments
- Notification_Managers Transaction_Ann Merchant
- Notification_Managers Transaction_Hjörleifur Pálsson
- Notification_Managers Transaction_Lisa Graver
- Notification_Managers Transaction_Richard Davies
FAQ
How many Alvotech (ALVO) stock options were granted to each independent board director?
What is the vesting schedule for Alvotech's (ALVO) board director stock options granted in 2025?
What is the exercise price for Alvotech's (ALVO) 2025 board director stock options?
What are the conditions for Alvotech (ALVO) board directors to exercise their stock options?
